Stearoyl lysophosphatidylcholine prevents lipopolysaccharide-induced extracellular release of high mobility group box-1 through AMP-activated protein kinase activation

International Immunopharmacology

Volumn 28, Issue 1, 2015, Pages 540-545

  Kim, Joung Min ^a   Han, Hui Jing ^a   Hur, Young Hoe ^a   Quan, Hui ^a,b   Kwak, Sang Hyun ^a   Choi, Jeong Il ^a,b   Bae, Hong Beom ^a,b  

^a Chonnam National University Medical School   (South Korea)

^b Chonnam National University   (South Korea)

Author keywords

HMGB1; LPS; Macrophage; Stearoyl lysophosphatidylcholine

Indexed keywords

ACETYL COENZYME A CARBOXYLASE; HIGH MOBILITY GROUP PROTEIN; HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE KINASE; LIPOPOLYSACCHARIDE; LYSOPHOSPHATIDYLCHOLINE; SMALL INTERFERING RNA; STEAROYL LYSOPHOSPATIDYLCHOLINE; UNCLASSIFIED DRUG; HIGH MOBILITY GROUP B1 PROTEIN; HMGB1 PROTEIN, MOUSE;

ANIMAL CELL; ANIMAL EXPERIMENT; ARTICLE; CONTROLLED STUDY; ENZYME ACTIVATION; LUNG LAVAGE; MALE; MOUSE; NONHUMAN; PERITONEUM MACROPHAGE; PRIORITY JOURNAL; PROTEIN PHOSPHORYLATION; PROTEIN SECRETION; PROTEIN TRANSPORT; ACUTE LUNG INJURY; ANIMAL; BAGG ALBINO MOUSE; BRONCHOALVEOLAR LAVAGE FLUID; CELL LINE; CELL SURVIVAL; CHEMICALLY INDUCED; CHEMISTRY; DRUG EFFECTS; LUNG; METABOLISM;

ACUTE LUNG INJURY; AMP-ACTIVATED PROTEIN KINASES; ANIMALS; BRONCHOALVEOLAR LAVAGE FLUID; CELL LINE; CELL SURVIVAL; HMGB1 PROTEIN; LIPOPOLYSACCHARIDES; LUNG; LYSOPHOSPHATIDYLCHOLINES; MACROPHAGES, PERITONEAL; MALE; MICE, INBRED BALB C;

EID: 84937938872     PISSN: 15675769     EISSN: 18781705     Source Type: Journal    
DOI: 10.1016/j.intimp.2015.07.010     Document Type: Article

References (31)

1. D. Musumeci, G.N. Roviello, and D. Montesarchio An overview on HMGB1 inhibitors as potential therapeutic agents in HMGB1-related pathologies Pharmacol. Ther. 141 2014 347 357
2. W. Huang, Y. Tang, and L. Li HMGB1, a potent proinflammatory cytokine in sepsis Cytokine 51 2010 119 126
3. H. Wang, O. Bloom, M. Zhang, J.M. Vishnubhakat, M. Ombrellino, J. Che, and et al. HMG-1 as a late mediator of endotoxin lethality in mice Science 285 1999 248 251
4. D. Tang, R. Kang, K.M. Livesey, C.W. Cheh, A. Farkas, P. Loughran, and et al. Endogenous HMGB1 regulates autophagy J. Cell Biol. 190 2010 881 892
5. H. Yanai, A. Matsuda, J. An, R. Koshiba, J. Nishio, H. Negishi, and et al. Conditional ablation of HMGB1 in mice reveals its protective function against endotoxemia and bacterial infection Proc. Natl. Acad. Sci. U. S. A. 110 2013 20699 20704
6. H. Yang, M. Ochani, J. Li, X. Qiang, M. Tanovic, H.E. Harris, and et al. Reversing established sepsis with antagonists of endogenous high-mobility group box 1 Proc. Natl. Acad. Sci. U. S. A. 101 2004 296 301
7. E.N. Ogawa, A. Ishizaka, S. Tasaka, H. Koh, H. Ueno, F. Amaya, and et al. Contribution of high-mobility group box-1 to the development of ventilator-induced lung injury Am. J. Respir. Crit. Care Med. 174 2006 400 407
8. D.G. Hardie, and M.L. Ashford AMPK: regulating energy balance at the cellular and whole body levels Physiology (Bethesda) 29 2014 99 107
9. M. Momcilovic, S.P. Hong, and M. Carlson Mammalian TAK1 activates Snf1 protein kinase in yeast and phosphorylates AMP-activated protein kinase in vitro J. Biol. Chem. 281 2006 25336 25343
10. D.G. Hardie AMP-activated protein kinase: an energy sensor that regulates all aspects of cell function Genes Dev. 25 2011 1895 1908
11. A. Nakano, H. Kato, T. Watanabe, K.D. Min, S. Yamazaki, Y. Asano, and et al. AMPK controls the speed of microtubule polymerization and directional cell migration through CLIP-170 phosphorylation Nat. Cell Biol. 12 2010 583 590
12. X. Zhao, J.W. Zmijewski, E. Lorne, G. Liu, Y.J. Park, Y. Tsuruta, and et al. Activation of AMPK attenuates neutrophil proinflammatory activity and decreases the severity of acute lung injury Am. J. Physiol. Lung Cell. Mol. Physiol. 295 2008 L497 L504
13. H.B. Bae, J.W. Zmijewski, J.S. Deshane, J.M. Tadie, D.D. Chaplin, S. Takashima, and et al. AMP-activated protein kinase enhances the phagocytic ability of macrophages and neutrophils FASEB J. 25 2011 4358 4368
14. K.M. Jeong, J.I. Choi, S.H. Lee, H.J. Lee, J.K. Son, C.S. Seo, and et al. Effect of sauchinone, a lignan from Saururus chinensis, on bacterial phagocytosis by macrophages Eur. J. Pharmacol. 728 2014 176 182
15. K. Tsoyi, H.J. Jang, I.T. Nizamutdinova, Y.M. Kim, Y.S. Lee, H.J. Kim, and et al. Metformin inhibits HMGB1 release in LPS-treated RAW 264.7 cells and increases survival rate of endotoxaemic mice Br. J. Pharmacol. 162 2011 1498 1508
16. I. Sevastou, E. Kaffe, M.A. Mouratis, and V. Aidinis Lysoglycerophospholipids in chronic inflammatory disorders: the PLA(2)/LPC and ATX/LPA axes Biochim. Biophys. Acta 2013 1831 42 60
17. P.J. Ojala, T.E. Hirvonen, M. Hermansson, P. Somerharju, and J. Parkkinen Acyl chain-dependent effect of lysophosphatidylcholine on human neutrophils J. Leukoc. Biol. 82 2007 1501 1509
18. M. Croset, N. Brossard, A. Polette, and M. Lagarde Characterization of plasma unsaturated lysophosphatidylcholines in human and rat Biochem. J. 345 Pt 1 2000 61 67
19. J.J. Yan, J.S. Jung, J.E. Lee, J. Lee, S.O. Huh, H.S. Kim, and et al. Therapeutic effects of lysophosphatidylcholine in experimental sepsis Nat. Med. 10 2004 161 167
20. G. Chen, J. Li, X. Qiang, C.J. Czura, M. Ochani, K. Ochani, and et al. Suppression of HMGB1 release by stearoyl lysophosphatidylcholine:an additional mechanism for its therapeutic effects in experimental sepsis J. Lipid Res. 46 2005 623 627
21. H.B. Bae, M. Li, J.K. Son, C.S. Seo, S.H. Chung, S.J. Kim, and et al. Sauchinone, a lignan from Saururus chinensis, reduces tumor necrosis factor-alpha production through the inhibition of c-raf/MEK1/2/ERK 1/2 pathway activation Int. Immunopharmacol. 10 2010 1022 1028
22. H.J. Han, M. Li, J.K. Son, C.S. Seo, S.W. Song, S.H. Kwak, and et al. Sauchinone, a lignan from Saururus chinensis, attenuates neutrophil pro-inflammatory activity and acute lung injury Int. Immunopharmacol. 17 2013 471 477
23. J.M. Tadie, H.B. Bae, J.S. Deshane, C.P. Bell, E.R. Lazarowski, D.D. Chaplin, and et al. Toll-like receptor 4 engagement inhibits adenosine 5'-monophosphate-activated protein kinase activation through a high mobility group box 1 protein-dependent mechanism Mol. Med. 18 2012 659 668
24. M.C. Towler, and D.G. Hardie AMP-activated protein kinase in metabolic control and insulin signaling Circ. Res. 100 2007 328 341
25. K.A. Coughlan, R.J. Valentine, N.B. Ruderman, and A.K. Saha AMPK activation: a therapeutic target for type 2 diabetes? Diabetes Metab. Syndr. Obes. 7 2014 241 253
26. S. Fogarty, and D.G. Hardie Development of protein kinase activators: AMPK as a target in metabolic disorders and cancer Biochim. Biophys. Acta 2010 1804 581 591
27. S. Jiang, D.W. Park, W.S. Stigler, J. Creighton, S. Ravi, V. Darley-Usmar, and et al. Mitochondria and AMP-activated protein kinase-dependent mechanism of efferocytosis J. Biol. Chem. 288 2013 26013 26026
28. D.W. Park, S. Jiang, Y. Liu, G.P. Siegal, K. Inoki, E. Abraham, and et al. GSK3beta-dependent inhibition of AMPK potentiates activation of neutrophils and macrophages and enhances severity of acute lung injury Am. J. Physiol. Lung Cell. Mol. Physiol. 307 2014 L735 L745
29. S. Jiang, D.W. Park, J.M. Tadie, M. Gregoire, J. Deshane, J.F. Pittet, and et al. Human resistin promotes neutrophil proinflammatory activation and neutrophil extracellular trap formation and increases severity of acute lung injury J. Immunol. 192 2014 4795 4803
30. W. Drobnik, G. Liebisch, F.X. Audebert, D. Frohlich, T. Gluck, P. Vogel, and et al. Plasma ceramide and lysophosphatidylcholine inversely correlate with mortality in sepsis patients J. Lipid Res. 44 2003 754 761
31. O. Murch, M. Collin, B. Sepodes, S.J. Foster, H. Mota-Filipe, and C. Thiemermann Lysophosphatidylcholine reduces the organ injury and dysfunction in rodent models of gram-negative and gram-positive shock Br. J. Pharmacol. 148 2006 769 777